Clinical Trials Logo

Clinical Trial Summary

This study is to evaluate the effectiveness and safety of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate, investigate the proper dialysis dose for Chinese CAPD patients.


Clinical Trial Description

This study is a prospective, randomized, parallel, controlled, multi-center clinical study of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate.It aims to investigate the proper dialysis dose for Chinese CAPD patients.At the same time,it can evaluate the effectiveness and safety of Chinese product Huaren Peritoneal Dialysate and peritoneal dialysis product Baxter Peritoneal Dialysate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01779557
Study type Interventional
Source Chinese PLA General Hospital
Contact
Status Completed
Phase Phase 4
Start date February 2013
Completion date September 2021

See also
  Status Clinical Trial Phase
Completed NCT00172211 - Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients N/A
Completed NCT02964429 - Determination In-vivo KUF for Diacap Pro Hemodialyser N/A
Completed NCT02525497 - Safety, Effectiveness and Manipulability Evaluation of a Domestic PD Machine N/A